Introduction: Antibiotic resistance has complicated the management of the draining ear. In this study, we examine the factors predisposing to resistance, as well as the role culture played in the management of these patients. Materials and Methods: A retrospective chart review was performed on all patients with a complaint of otorrhea during a 3-year period. Demographic factors, the patients diagnosis, previous antimicrobial use, the organism isolated, the resistance pattern of the organism, the treatment instituted, the treatment changed, and the efficacy of treatment were all examined. Results: Previous antibiotic use resulted in a significantly increased rate of resistance only for the diagnosis of otitis externa ( p = 0.01). No other factors were found to be clinically significant. The previous use of ototopical quinolones was shown to be correlated with a significant increase in quinolone resistance ( p = 0.01). Methicillin-resistant Staphylococcus aureus isolated was shown to have 60% and 33% resistance rates to clindamycin and trimethoprim/sulfamethoxazole, respectively. The overall treatment failure rate was 36% but rose to 50% for infections involving highly resistant bacteria ( p = 0.01). Treatment was changed based on culture results in 21% of cases. Conclusion: Previous antibiotic use is correlated with increased bacterial resistance in the case of otitis externa. Highly resistant bacteria were associated with an increased rate of treatment failure. Culture plays an essential role in the management of refractory otorrhea. Key Words: Antibiotic resistanceVCultureVEar drainageVMethicillin-resistantVStaphylococcus aureusV OtorrheaVPseudomonas. Otol Neurotol 30:339Y343, 2009.
Aural drainage is a frequently encountered otolaryngological complaint. It may be due to a variety of causes including otitis externa, myringitis, otitis media with perforation, infected cholesteatoma, and otorrhea after tympanostomy tube or mastoiditis. Specific choices of antibiotic therapy are generally based on empirical decisions regarding the most common bacteria for a given diagnosis. Because rates of resistant bacteria have been thought to be low, cultures are often not obtained from draining ears. Based on a significant rise in recent years of resistant bacteria, the role of culturing in the treatment of the draining ear requires reevaluation.
In a previous study from our group, culture data from chronically draining ears were examined for a 3-year period to investigate potential relationships between specific diagnoses at the time of culture, clinical findings, types and rates of resistant organisms, and otomycosis. We hypothesize that resistant bacteria are associated with previously treated patients and a higher rate of treatment failures. The purpose of this study is to further define the role of culture in the management of resistant otorrhea. We examine the factors predisposing to bacterial resistance, the resistance patterns of specific organisms, and how the culture results were used in the management of these patients.
MATERIALS AND METHODS
The clinic charts and culture results of 170 patients with draining ears that were cultured and with various underlying diagnoses were retrospectively reviewed. These diagnoses included otitis externa, myringitis, otitis media with perforation, infected cholesteatoma, otorrhea after tympanostomy tube placement, and chronic mastoiditis (open mastoid cavities). It is our practice to obtain a culture in patients with a history of recurrent infections or resistant organisms and those that do not respond to empirical therapy and have severe infections, or to rule out otomycosis. Antifungal therapy was started empirically based on clinical suspicion. All culture specimens were obtained in the outpatient setting of an academic otology practice from October 1, 2003 , to September 30, 2006 . This study was approved by the institutional review board of the University of Oklahoma Health Sciences Center (IRB13033). Funding for this study was intradepartmental.
Information obtained from the clinical chart included the primary and secondary diagnoses, previous treatment with oral or topical antibiotics, suspicion of fungus at the time of the initial examination, culture results, and success of treatment. Culture-specific data included: the organism, presence of resistance, and sensitivity spectrum. Each culture sensitivity was graded on a scale as follows: 0 = sensitive to all commonly used antibiotics, 1 = resistant to some oral/topical antibiotics, and 2 = resistant to all oral antibiotics, only sensitive to intravenous antibiotics. Bacteria given a score of 1 or 2 were deemed to be Bresistant.[ Cultures that showed intermediate resistance (minimum inhibitory concentration = 8) to a particular antibiotic were considered sensitive to that antibiotic for the purposes of this study. It should be noted that sensitivity to linezolid was typically not included in the culture data. The patient charts were reviewed in all cases for clinical findings suggestive of a fungal infection (fungal mats or spores). Patients with persistent or recurrent infections with the same organisms within 3 months were considered a single infection event rather than a separate infection. Culture results were, therefore, considered separate events if 3 months had elapsed between cultures. Potential correlations between bacterial resistance grade, previous oral or topical treatment, diagnosis, presence of otomycosis, and treatment outcome were analyzed using a Fisher's exact t test. The level of statistical significance was set at p G 0.05.
RESULTS
Clinical information from 170 patients was reviewed, comprising 243 infection events from 188 ears and 286 different cultures. The distribution was predominantly male (101:79), and the patient ages ranged from 3 months to 90 years, with a mean age of 34.6 years. Previous
FIG. 1.
Relationship between previous antibiotic use and the development of resistance analyzed by diagnosis type. Only otitis externa showed a significant difference in resistance rate between patients who had not received previous antibiotics and those that did.
FIG. 2.
Relationship between previous quinolone use and the development of quinolone resistance. There was a significant difference in quinolone resistance between those patients who had recently used ototopical quinolones and those who had not. The change quinolone resistance when examining previous oral quinolone use did not reach statistical significance.
antibiotic use was correlated with an increased incidence of resistance organisms (resistant grade = 1 or 2) in culture for each specific diagnosis. This relationship was significant for otitis externa ( p = 0.014) but not the other diagnoses. As seen in Figure 1 , the rate of resistance increased from 33% to 75% in patients with otitis externa that had used previous antibiotics.
When looking at previous oral antibiotic use, 44% of infection events had resistant bacteria with no previous oral antibiotic use, whereas 51% of events had resistant bacteria with previous recent antibiotic use. Patients with no previous ototopical antibiotics showed a 47% rate of resistance, whereas patients who were previously treated with ototopical antibiotics had a 46% resistance rate. These relationships were not statistically significant.
Quinolone resistance was also examined in this study. The rate of quinolone resistance was analyzed for a relationship with previous treatment with oral and topical quinolones (Fig. 2) . Quinolone resistance was seen in 5% of patients who had not been on oral quinolones and 14% of patients who had been treated previously. This relationship was not significant. However, previous topical quinolone use was significantly associated with an increased rate of quinolone-resistant organisms ( p = 0.01). The rate of resistance was 4% and 17% for patients who had no previous topical quinolones and those who had been treated, respectively.
Highly resistant organisms (resistance grade = 2) represented 16 cultures comprising 14 infection events in 12 patients. Staphylococcus epidermidis was the most commonly isolated organism, followed by methicillinresistant Staphylococcus aureus (MRSA), and Achromobacter xylosoxidans. Complete lists of resistant and highly resistant bacteria are given in Tables 1 and 2. MRSA infections represented 15 infections events and 23 cultures. Of these 15 events, 60% of the MRSA was resistant to clindamycin, 33% was resistant to trimethoprim/ sulfamethoxazole, and 13% were resistant to both (considered resistance Grade 2). Treatments for these highly resistant organisms included linezolid, intravenous vancomycin, betadine irrigations, and surgical debridement. Pseudomonas infections represented 49 cultures from 47 infection events in 37 patients. Quinolone resistance was found to be present in 17.9% of these pseudomonal infection events.
The efficacy of treatment and factors associated with treatment failure were also examined. Overall treatment was not effective in resolving otorrhea in 21% (52/243) of events. In highly resistant bacteria (resistance grade = 2), the treatment failure rate was 50%. The difference between the treatment failure rate of highly resistant bacteria and the group as a whole was statistically significant ( p = 0.014).
The diagnoses most commonly associated with treatment failures were chronic otitis media, posttube otorrhea, and chronic mastoiditis. None of these relationships were statistically significant. The organisms most commonly associated with treatment failures included S. epidermidis (44%), MRSA (12%), and Pseudomonas aeruginosa (12%). Fungus was isolated in 23% of infection events involved with treatment failures.
Clinic charts were reviewed for documented changes in antibiotic therapy based on culture results. Overall, antimicrobial treatment was changed based on the culture results in 21% of cases. When looking at refractory cases of otorrhea (those that had failed previous treatment), antimicrobial treatment was changed in 36% of cases. There was a statistically significant difference in the rates of altered antibiotic therapy between infections events that had been previously treated (refractory cases) and those that had not ( p = 0.004). In addition, alterations in antibiotic therapy were more common for highly resistant bacteria (46%).
DISCUSSION
The rise of antibiotic resistance has complicated the management of bacterial infections in all areas including the head and neck. This study seeks to further define relationship between previous antibiotic use and resistance, and the effect of culture on the management of these patients. Previous antibiotic use is a risk factor for the development of resistant organisms in acute otitis media, and those resistant organisms are associated with an increased rate of treatment failure and complications (1). The growing incidence of MRSA in both nosocomial and community-acquired infections for the past decade has been particularly concerning. Few studies have examined the role of resistant bacteria in the chronically draining earVthose that have shown the rate of MRSA infection to be between 6 and 12% in the setting of posttympanostomy tube otorrhea and acute otitis (2, 3) . In addition to MRSA, resistant strains of bacteria genera, including Corynebacter and Pseudomonas, are also being found in draining ears. The emergence of quinolone-resistant organisms are of particular concern in otology, given the widespread use of ototopical quinolones (4, 5) .
Patients with chronically draining ears are often exposed to multiple antimicrobial agents, placing them at higher risk for developing a resistant infection. At our institution, a high rate (50.6%) of resistant bacteria was seen in cultured otorrhea. In addition to resistant bacteria, chronic ear infections have high rates of fungal or mixed infections, and these types of infections seemed to be increasing in frequency (5) . Ineffectively treated otomycosis is also a frequent cause of treatment failure (5Y7).
In this study, previous antibiotic use was significantly correlated with an increased rate of resistance in this study in otitis externa but not for other diagnosis categories. This may be due to differences in the organisms between diagnoses or to inherent differences in antibiotic exposure for these patients. In addition, these patients may be more likely to have been recently treated at the time of the culture. Other risk factors for resistance, such as recent hospitalization, contact with persons with resistant infections, occupation in the health care sector, and previous resistant infections were not examined (1, 8, 9) . Assessing these factors may better predict which patients may have resistant organisms.
Neither oral nor topical antibiotic use demonstrated a significant association with increased resistance overall. This is consistent with the findings of previous studies (10). However, it was found that patients who were previously treated with topical quinolones were more likely to have a quinolone-resistant organism. This is a worrisome trend because topical fluoroquinolones have been the mainstay for treating ear infections. Quinolone-resistant Pseudomonas was found in 17.9% of Pseudomonas infections in this study (6) . Quinolone-resistant Pseudomonas has been reported in a group of pediatric patients with recurrent otorrhea refractory to initial treatment (11) and has also been seen in biofilms of patients with resistant posttympanostomy tube otorrhea (4) .
MRSA was present in 6.1% of infection events. Isolates demonstrated a high rate of resistance to clindamycin and moderate rate of trimethoprim/sulfamethoxazole resistance. No infections demonstrated resistance to vancomycin. These findings strongly suggest that empiric treatment of ear infections with trimethoprim/sulfamethoxazole and clindamycin to cover MRSA may not be effective. Some MRSA infections were resistant to all available oral antibiotics and required intravenous antibiotics. Much of the study period was prior to the common availability of linezolid, which may provide an alternative to intravenous therapy in these patients. Resistant bacteria seen in this study were not limited to MRSA. A wide array of other highly resistant organisms (resistance grade = 2) were present in the study as seen in Table 2 .
Initial treatment did not resolve otorrhea in 36% of cases. There was no significant association with the presence of resistant bacteria (resistance grade = 1 or 2) and treatment failure. However, when highly resistant bacteria (resistance grade = 2) were examined, only 50% of infections resolved with initial therapy. Resistant Staphylococcus species, including MRSA, were the most commonly isolated organisms isolated in treatment failures, followed by P. aeruginosa. Coticchia and Dohar (12) also observed a greater frequency of refractory infections and prolonged antibiotic use in patients with posttympanostomy tube otorrhea containing MRSA. Staphylococcus epidermidis is thought to be normal flora in the ear canal; however, in many cases, this organism was shown to be highly resistant in the cultured otorrhea. Pathogenic S. epidermidis has been seen in indwelling implantable devices but has not been well described in the ear.
In 21% of cases overall, antimicrobial coverage was altered based on the culture results. This rate increased to 46% when highly resistant organisms were involved. In general, these alterations were based on the presence of resistant bacteria in the cultures. Therapy was also changed when a fungal infection was diagnosed. On occasion, culture results can help to confirm the choice of empirical therapy. For these reasons, we feel the cultures play an important role in the management of otorrhea at this institution.
There are several limitations to this study. All patients in this study were treated in a large academic setting, primarily by otologists. Therefore, patients in this study may be more likely to have been previously treated with antibiotics, which may lead to a higher rate of resistance. The retrospective nature of this study may present some recall bias particularly in regard to physical findings at the time of diagnosis.
There are also geographical limitations to the applicability of the data. Regional variations in bacterial resistance may also affect the ability to generalize these findings to other populations (13) . Temporal limitations exist as well, as resistance rates have been shown to change rapidly over a relatively short period of time. A recent study reported a 3-fold increase in the rate of community-acquired MRSA from 21% to 64% for a 5-year period (11) .
The role of ototopical treatment in culture-directed therapy bears mentioning. The clinical significance of bacterial resistance in the draining ear is unclear, given potentially high concentrations of otopical drugs in the ear. The high concentration of an ototopical solution in the middle ear space may overcome the minimum inhibitory concentration of some bacteria. However, Ohyama et al. (14) observed that concentrations of ototopical drops that have been reported at the middle ear mucosa vary greatly and may be dependent on the amount of drainage from the ear. Our observation that treatment failure correlates with the presence of highly resistant bacteria further demonstrates the significance of bacterial resistance in the draining ear. The effect of MRSA on clinical outcomes has been described by others in posttympanostomy tube otorrhea (12) . Therefore, the use of ototopical agents does not seem to safeguard against the effects of resistant bacteria in these cases.
The cost-benefit of initial cultures in these diagnoses remains unresolved. The cost of a culture at this institution is approximately US $40. This cost must be weighed against the morbidity of continued infection, as well, as lost time and resources because of additional clinic visits, treatment, and missed work.
CONCLUSION
In conclusion, a relationship between antibiotic resistance and both previous antibiotic use and treatment failure was seen; however, these patterns do not seem to be uniform or clear cut. Patients with recent antibiotic treatment for otitis externa are at a higher risk for resistant bacteria. In addition, quinolone resistance was found to be increased when a patient was previously treated with an ototopical quinolone. Highly resistant bacteria are associated with higher rates of treatment failures, and culture results may alter antimicrobial management in 20 to 40% of cases. With these findings, we would recommend obtaining cultures in all cases of chronically draining ears that are refractory to initial treatment and in those patients considered to be at high risk for bacterial resistance.
